Abstract
This cohort study examines trends in medication use among patients hospitalized for COVID-19–related treatment in a large US university health care system from the start of stay-at-home orders in March 2020 throughout the rest of the year.
MeSH terms
-
Adenosine Monophosphate / analogs & derivatives
-
Adenosine Monophosphate / therapeutic use
-
Adult
-
Alanine / analogs & derivatives
-
Alanine / therapeutic use
-
Angiotensin Receptor Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Anti-Bacterial Agents / therapeutic use
-
Anti-Inflammatory Agents / therapeutic use
-
Anticoagulants / therapeutic use
-
Antiviral Agents / therapeutic use
-
Azithromycin / therapeutic use
-
COVID-19 / epidemiology
-
COVID-19 Drug Treatment*
-
California / epidemiology
-
Colchicine / therapeutic use
-
Dexamethasone / therapeutic use
-
Drug Therapy, Combination
-
Drug Utilization Review*
-
Female
-
Hospitalization
-
Humans
-
Hydrocortisone / therapeutic use
-
Hydroxychloroquine / therapeutic use
-
Male
-
Pandemics
-
SARS-CoV-2
Substances
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Anti-Bacterial Agents
-
Anti-Inflammatory Agents
-
Anticoagulants
-
Antiviral Agents
-
remdesivir
-
Adenosine Monophosphate
-
Hydroxychloroquine
-
Dexamethasone
-
Azithromycin
-
Alanine
-
Colchicine
-
Hydrocortisone